Advanced search
Publication Cover
Journal of Medical Economics Volume 23, 2020 - Issue 11
Submit an article Journal homepage
3,378
Views
10
CrossRef citations to date
0
Altmetric
Health Financing

Vaso-occlusive crises and costs of sickle cell disease in patients with commercial, Medicaid, and Medicare insurance – the perspective of private and public payers

Nirmish R. Shaha Duke Adult Comprehensive Sickle Cell Center, Durham, NC, USA
,
Menaka Bhorb Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA
,
Dominick Latremouille-Viauc Analysis Group, Inc, Montreal, QC, CanadaCorrespondence[email protected]
,
Vikash Kumar Sharmad Novartis Healthcare Pvt. Ltd, Hyderabad, India
,
Gary A. Puckreine National Minority Quality Forum, Washington, DC, USA
,
Patrick Gagnon-Sanschagrinc Analysis Group, Inc, Montreal, QC, Canada
,
Ankur Khared Novartis Healthcare Pvt. Ltd, Hyderabad, India
,
Mukesh Kumar Singhd Novartis Healthcare Pvt. Ltd, Hyderabad, India
,
Elizabeth Serrac Analysis Group, Inc, Montreal, QC, Canada
,
Mikhaïl Davidsonc Analysis Group, Inc, Montreal, QC, Canada
,
Liou Xue National Minority Quality Forum, Washington, DC, USA
&
Annie Guerinc Analysis Group, Inc, Montreal, QC, Canada
 show all
Pages 1345-1355 | Received 27 May 2020, Accepted 10 Aug 2020, Published online: 09 Sep 2020

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Meghan E. Gallagher, Anjulika Chawla, Brenna L. Brady & Sherif M. Badawy. (2022) Heterogeneity of the long-term economic burden of severe sickle cell disease: a 5-year longitudinal analysis. Journal of Medical Economics 25:1, pages 1140-1148.
Read now

Articles from other publishers (9)

Chuka Udeze, Kristin A. Evans, Yoojung Yang, Timothy Lillehaugen, Janna Manjelievskaia, Urvi Mujumdar, Nanxin Li & Biree Andemariam. (2023) Economic and Clinical Burden of Managing Sickle Cell Disease with Recurrent Vaso-Occlusive Crises in the United States. Advances in Therapy 40:8, pages 3543-3558.
Crossref
Jean‐Antoine Ribeil, Galia Pollock, Haydar Frangoul & Martin H. Steinberg. (2023) An integrated therapeutic approach to sickle cell disease management beyond infancy. American Journal of Hematology 98:7, pages 1087-1096.
Crossref
Christopher Rudge & Dianne Nicol. 2023. Handbook of Bioethical Decisions. Volume I. Handbook of Bioethical Decisions. Volume I 49 77 .
Clarisse Lobo, Patricia Moura, Delaine Fidlarczyk, Jane Duran, Roberto Barbosa, Thais Oliveira, Emilia Matos do Nascimento, Nickhill Bhakta & Jane S. Hankins. (2022) Cost analysis of acute care resource utilization among individuals with sickle cell disease in a middle-income country. BMC Health Services Research 22:1.
Crossref
Deepa Manwani, Arthur L. Burnett, Jincy Paulose, Glorian P. Yen, Tanya Burton, Amy Anderson, Sara Wang, Soyon Lee & Santosh L. Saraf. (2022) Treatment patterns and burden of complications associated with sickle cell disease: A US retrospective claims analysis. eJHaem 3:4, pages 1135-1144.
Crossref
Simon C. Mathews, Sergey Izmailyan, Frances A. Brito, Jose-Miguel Yamal, Osama Mikhail & Frances L. Revere. (2022) Prevalence and Financial Burden of Digestive Diseases in a Commercially Insured Population. Clinical Gastroenterology and Hepatology 20:7, pages 1480-1487.e7.
Crossref
Zachary Baldwin, Boshen Jiao, Anirban Basu, Joshua Roth, M. A. Bender, Zizi Elsisi, Kate M. Johnson, Emma Cousin, Scott D. Ramsey & Beth Devine. (2022) Medical and Non-medical Costs of Sickle Cell Disease and Treatments from a US Perspective: A Systematic Review and Landscape Analysis. PharmacoEconomics - Open 6:4, pages 469-481.
Crossref
Kate M. Johnson, Boshen Jiao, M. A. Bender, Scott D. Ramsey, Beth Devine & Anirban Basu. (2022) Development of a conceptual model for evaluating new non-curative and curative therapies for sickle cell disease. PLOS ONE 17:4, pages e0267448.
Crossref
Stephanie O. Ibemere, Paula Tanabe, Emily Bonnabeau, Gary Rains, Kern Eason, Marian F. Earls & Nirmish Shah. (2021) Awareness and Use of the Sickle Cell Disease Toolbox by Primary Care Providers in North Carolina. Journal of Primary Care & Community Health 12, pages 215013272110490.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.